DiscoverChilCast: Healthcare Tech TalksData Liquidity for Clinical Trials: Patient Autonomy and the Rise of AI with UBC and SEQSTER
Data Liquidity for Clinical Trials: Patient Autonomy and the Rise of AI with UBC and SEQSTER

Data Liquidity for Clinical Trials: Patient Autonomy and the Rise of AI with UBC and SEQSTER

Update: 2024-05-29
Share

Description

Join us on this episode of the Chilcast as we discuss use cases for real world data and the future of medical research. We're joined by industry experts Aaron Berger, SVP of Evidence Development Solutions at the clinical research organization UBC, and Ardy Arianpour, CEO and Co-Founder of SEQSTER, the first one-click, patient-mediated  platform for clinical data aggregation.

Hear how these two have worked together to enable greater data liquidity in the clinical trials process, reducing physician administrative burden (and cost), creating new opportunities to accelerate the development process by expediting recruitment and the collection of medical histories. As health data continues to be digital gold for the companies that are able to effectively leverage it, learn how one partnership around RWD has had far-reaching implications about the future of trial design, post-market surveillance, and more.

Be sure to follow us on LinkedIn and take a look at our research to stay up to date on the health IT industry.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Data Liquidity for Clinical Trials: Patient Autonomy and the Rise of AI with UBC and SEQSTER

Data Liquidity for Clinical Trials: Patient Autonomy and the Rise of AI with UBC and SEQSTER

Chilmark Research